CD27 Ligand

CD27 Ligand

CD27 Ligand Informations sur la molécule

Molecule Name
CD70 antigen
Alias de la molécule
CD70,CD27LG,TNFSF7,TNFSF7G,CD27L
Drug Development Progress
Nombre de médicaments cliniques37
Nombre de médicaments commercialisés0
Phase de R&D la plus avancéePhase 2 Clinical
Alias de la cible
CD70 antigen,Surface Antigen CD70,LPFS3,CD27L,Tumor necrosis factor ligand superfamily member 7,CD27LG,CD27-L,CD70,CD70 Molecule,TNFSF7,Tumor Necrosis Factor (Ligand) Superfamily, Member 7,Tumor Necrosis Factor Ligand 8A,Ki-24 Antigen,TNLG8A,CD27 Ligand
Contexte de la molécule
Cluster of Differentiation 70 (CD70) is also known as CD27 ligand (CD27L / CD27LG), TNFSF7, TNFSF7G, is a type II transmembrane glycoprotein belonging to the TNF superfamily (TNFSF) and is a surface antigen found on activated T-and B-lymphocytes and mature dendritic cells. Binding of CD70 to its receptor CD27 induces in priming, effector functions, differentiation and memory formation of T-cells, and thus is invloved in the biological processes including T-cell activation, the proliferation of costimulated T-cells, as well as the generation of cytolytic T-cells. CD70 on T cells provides costimulatory signals that are required for T cell proliferation, clonal expansion and the promotion of effector T cell formation. CD70 on mouse B cell has been shown to inhibit terminal differentiation of activated B cells into plasma cells and enhances commitment to memory B cell responses. CD70 induces proliferation and IFNγ production, on NK cells.

CD27 Ligand Liste de produits

Species
  • Human(12)
  • Mouse(3)
Tag
  • His Tag(6)
  • His Tag & Flag Tag(3)
  • Mouse IgG Fc Tag(2)
  • Fc Tag(1)
  • His Tag & Avi Tag(1)
  • His Tag & Avi Tag & Flag Tag(1)
  • Llama IgG Fc Tag(1)
Host
  • HEK293(15)
Conjugate
  • Unconjugated(7)
  • Biotin-labeled(2)
  • FITC Labeled(2)
  • AF488 Labeled(1)
  • AF647 Labeled(1)
  • APC Labeled(1)
  • PE Labeled(1)
Grade
  • RUO(15)
Low Endotoxin
  • Yes(4)
  • No(11)
You Have Viewed 1-10 Of 15 Results
  • 1
  • 2

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity

Plateforme de commerce de projets d'anticorps

Nom du projetPhase du projetType de moléculeSource de moléculeDomain thérapeutiqueIndication
CD70 VHH - 01LeadMonoclonalNanobodyHematological MalignancyNon-hodgkin lymphoma
Nom du projet
CD70 VHH - 01
Phase du projet
Lead
Type de molécule
Monoclonal
Source de molécule
Nanobody
Domain thérapeutique
Hematological Malignancy
Indication
Non-hodgkin lymphoma
Resources

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
CusatuzumabARGX-110; JNJ-4550Phase 2 ClinicalArgenx Se
Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Neoplasms
Details
ARX-305JNJ-0631; ARX-305; NCB-002Phase 2 ClinicalAmbrx Inc
Lymphoma; Neoplasms
Details
CD70.CAR NK cell therapy (Bellicum Pharma)Phase 2 ClinicalBellicum Pharmaceuticals Inc, The University Of Texas MD Anderson Cancer Center
Hodgkin Disease; Lymphoma, B-Cell
Details
ADI-270ADI-270Phase 2 ClinicalAdicet Bio Inc
Carcinoma, Renal Cell
Details
CD70 Targeted CAR-T Cells Therapy(UTC Therapeutics)Phase 2 ClinicalUTC Therapeutics Inc
Lymphoma; Solid tumours; Urologic Neoplasms
Details
Cord Blood-derived CAR NK Cells Targeting CD19/CD70(Shanghai Tongji Hospital)Phase 2 ClinicalShanghai Tongji Hospital
Lymphoma, B-Cell
Details
MP0533MP0533Phase 2 ClinicalMolecular Partners Ag
Leukemia, Myeloid, Acute
Details
CTX-131CTX-131Phase 2 ClinicalCrispr Therapeutics Ag
Carcinoma, Renal Cell; Esophageal Neoplasms; Leukemia, Myeloid, Acute; Lymphoma, B-Cell; Lymphoma, T-Cell; Mesothelioma; Neoplasms; Pancreatic Neoplasms; Uterine Cervical Neoplasms
Details
GD2/CD70 Bi-specific CAR-T Cell Therapy (Shenzhen Geno-Immune Medical Institute)bi-4SCAR GD2/CD70Phase 2 ClinicalShenzhen Geno-Immune Medical Institute
Neoplasms
Details
CD19/70 Bi-specific CAR-T Cell Therapy (Shenzhen Geno-Immune Medical Institute)Phase 2 ClinicalShenzhen Geno-Immune Medical Institute
Leukemia, B-Cell; Lymphoma, B-Cell
Details
PSMA/CD70 Bi-specific CAR-T Cell Therapy (Shenzhen Geno-Immune Medical Institute)bi-4SCAR PSMA/CD70Phase 2 ClinicalShenzhen Geno-Immune Medical Institute
Neoplasms
Details
SEA-CD70SEA-CD70; PF-08046040Phase 1 ClinicalSeagen Inc
Leukemia, Myeloid, Acute; Myelodysplastic Syndromes
Details
anti-CD70 CAR T-cell therapy linked with modified IL-8 receptor (University of Florida)Phase 1 ClinicalUniversity Of Florida
Glioblastoma; Glioma; Ovarian Neoplasms; Pancreatic Neoplasms
Details
CAR BCMA-CD70-T cells therapy (The Fifth Medical Center Of Pla General Hospital)Phase 1 ClinicalThe Fifth Medical Center Of Pla General Hospital (Formerly 307 Hospital)
Neoplasms, Plasma Cell
Details
Novel CAR-ITNK Cells Targeting CD70 and CLL1 therapy (Tongji Hospital)Phase 1 ClinicalTongji Hospital
Leukemia, Myeloid, Acute
Details
TGFBR-2 KO CD70 CAR NK cell therapy (The University Of Texas MD Anderson Cancer Center)Phase 1 ClinicalThe University Of Texas MD Anderson Cancer Center
Adenocarcinoma, Clear Cell
Details
GEN1160GEN-1160; GEN1160Phase 1 ClinicalGenmab A/S
Carcinoma, Renal Cell; Lymphoma, Non-Hodgkin; Nasopharyngeal Carcinoma
Details
CD70-CAR-NK Cell Therapy(Second Affiliated Hospital School Of Zhejiang University School Of Medicine)Phase 1 ClinicalSecond Affiliated Hospital School Of Zhejiang University School Of Medicine
Leukemia, Myeloid, Acute; Lymphoma, T-Cell
Details
Anti-CD70-CAR-T Cell therapy(First Song Biotechnology)Phase 1 ClinicalShanghai First Song Therapeutics Co Ltd
Carcinoma, Renal Cell
Details
IB-T101Phase 1 ClinicalInceptor Bio LLC
Carcinoma, Renal Cell
Details
Anti-BCMA/CD70 CAR-T cells therapy(The Children'S Hospital, Zhejiang University School Of Medicine)Phase 1 ClinicalThe Children'S Hospital, Zhejiang University School Of Medicine
Lupus Erythematosus, Systemic; Nephrosis
Details
CD70 UCAR T cells Therapy (Nanjing Calmhome Cell and Gene Engineering Institute)CHT101; CHT-101Phase 1 ClinicalNanjing Calmhome Cell and Gene Engineering Institute Co Ltd
Carcinoma, Renal Cell; Glioma; Lupus Erythematosus, Systemic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Nasopharyngeal Carcinoma; Neoplasm Metastasis; Ovarian Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Uterine Cervical Neoplasms
Details
Chimeric Antigen Recertor Treatment Targeting CD70(Baylor College of Medicine)Phase 1 ClinicalBaylor College Of Medicine
Bone Marrow Neoplasms; Kidney Neoplasms; Leukemia, B-Cell; Leukemia, Myeloid, Acute; Leukemia, T-Cell; Lymphoma; Sarcoma; Solid tumours
Details
CAR T-cell Therapy Directed to CD70(St Jude Children's Research Hospital)Phase 1 ClinicalSt. Jude Children'S Research Hospital
Hematologic Neoplasms; Leukemia, Myeloid, Acute; Lymphoma; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma
Details
CD70-targeted CAR-NKT Cells Therapy (CureGenetics)CGC729; CGC-729Phase 1 ClinicalSuzhou Cure Genetics Biosciences Co Ltd
Carcinoma, Renal Cell; Solid tumours
Details
ALLO-329ALLO-329Phase 1 ClinicalAllogene Therapeutics Inc
Anti-synthetase Syndrome; Dermatomyositis; Lupus Erythematosus, Systemic; Muscular Diseases; Myositis; Scleroderma, Systemic
Details
CD70-CART(Hrain)HR010; HR-010Phase 1 ClinicalHrain Biotechnology Co Ltd
Carcinoma, Renal Cell
Details
Anti-CD19/CD70 NK cell therapy (Zhejiang University)Phase 1 ClinicalZhejiang University
Lymphoma, B-Cell
Details
CD70 CAR-T cell therapy (Chongqing Precision Biotech)Phase 1 ClinicalChongqing Precision Biotechnology Co Ltd
Arthritis, Juvenile; Carcinoma, Renal Cell; Dermatomyositis; Genital Neoplasms, Female; Lung Neoplasms; Neoplasm Metastasis; Neoplasms; Ovarian Neoplasms; Scleroderma, Systemic; Sjogren's Syndrome; Solid tumours; Thymoma; Thyroid Carcinoma, Anaplastic; Uterine Cervical Neoplasms
Details
IMM-40HIMM-40H; IMM40HPhase 1 Clinical
Hematologic Neoplasms; Neoplasms; Solid tumours
Details
ALLO-316ALLO-316Phase 1 ClinicalCellectis Sa, Overland Pharmaceuticals (Shanghai) Co Ltd
Carcinoma, Renal Cell; Leukemia, Myeloid, Acute
Details
CD70 CAR T-cell therapy (Yake Biotechnology)Phase 1 ClinicalZhejiang University
Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Multiple Myeloma
Details
C-4-29Phase 1 ClinicalChongqing Precision Biotechnology Co Ltd
Carcinoma, Renal Cell; Lupus Erythematosus, Systemic; Multiple Myeloma
Details
[68Ga]Ga-NOTA-RCCB6ClinicalHuashan Hospital
Kidney Neoplasms; Lymphoma
Details
[18F]RCCB6ClinicalHuashan Hospital
Kidney Neoplasms
Details
CGC-738CGC-738; CGC738ClinicalSuzhou Cure Genetics Biosciences Co Ltd
Carcinoma, Renal Cell
Details
CD19/CD70 CAR-NK cells therapy (Rongu Biotechnology)RG-1970ClinicalHangzhou Rongu Biotechnology Co Ltd
Lymphoma, B-Cell; Neoplasms
Details
Customer Reviews